Breast CAncer REsearch at duke
Michael B. Kastan, MD, PhD
Executive Director, Duke Cancer Institute
Professor of Pharmacology and Cancer Biology
Professor of Pediatrics
Forty-two years ago, the United States Congress passed the “National Cancer Act”, the so-called ‘war on cancer’. We knew so little about the biology of cancer at that time and had so few effective therapies, that it was unrealistic for anyone to expect rapid progress at that time.
All that has changed – over the past 40+ years, through research we have learned a tremendous amount about how normal cells transform into cancer cells and new and targeted therapies are rapidly being developed. There is a palpable excitement in the field as people see the potential to develop more effective and less toxic treatments. It is a frustrating time for the federal government to cut back on the dollars it spends on medical research and for pharmaceutical companies to reduce their spending on research and development.
There are fourteen million Americans today who are cancer survivors. Thus, we clearly are having more successes. However, there is a price tag that our patients pay for successful current therapies because of the short-term and long-term toxicities of surgeries, radiation therapies, and chemotherapies.
We now have the potential to develop therapies that are both more effective and less toxic. With the gaps in funding from the government and industry, the only way to achieve our potential in developing new cancer therapies is with philanthropic support. Activities like “Tee it up for a Cure” are invaluable partners in our war on cancer.
We cannot win the battles or the war without you.
Where your donations go
100% of the funds donated to the Chapel Hill Breast Cancer Foundation go directly to supporting discovery phase breast cancer research projects at Duke, UNC and Wake Forest Universities.
Your past donations are making a difference today.
Today's donations will make a difference tomorrow.